Literature DB >> 17765906

The impact of adding trunk motion to the interpretation of the role of joint moments during normal walking.

Mausam Patel1, Mukul Talaty, Sylvia Ounpuu.   

Abstract

Biomechanical model assumptions affect the interpretation of the role of the muscle or joint moments to the segmental power estimated by induced acceleration analysis (IAA). We evaluated the effect of modeling the pelvis and trunk segments as two separate segments (8 SM) versus as a single segment (7 SM) on the segmental power, support of the body, knee and hip extension acceleration produced by the joint moments during the stance phase of normal walking. Significant differences were observed in the contribution of the stance hip abductor and extensor moments to support, ipsilateral knee and hip acceleration, and ipsilateral thigh and upper body power. The primary finding was that the role of the stance hip moment in generating ipsilateral thigh and upper body power differed based on degrees of freedom in the model. Secondarily, the magnitude of contributions also differed. For example, the hip abductor and extensor moments showed greater contribution to support, hip and knee acceleration in the 8 SM. IAA and segment power analysis are sensitive to the degrees of freedom between the pelvis and trunk. There is currently no gold standard by which to evaluate the accuracy of IAA predictions. However, modeling the pelvis and trunk as separate segments is closer to the anatomical architecture of the body. An 8 SM appears to be more appropriate for estimating the role of joint moments, particularly to motion of more proximal segments during normal walking.

Mesh:

Year:  2007        PMID: 17765906     DOI: 10.1016/j.jbiomech.2007.06.031

Source DB:  PubMed          Journal:  J Biomech        ISSN: 0021-9290            Impact factor:   2.712


  1 in total

1.  Muscle function may depend on model selection in forward simulation of normal walking.

Authors:  Ming Xiao; Jill S Higginson
Journal:  J Biomech       Date:  2008-09-19       Impact factor: 2.712

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.